Filed 2.8y ago· Aug 13, 2023
30 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Merck
MRK
$1K-$15K
+12.8% vs S&P 500
Trade dateJul 14, 2023
Stock
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–54 of 54
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Jazz Pharmaceuticals PLC
JAZZ
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Shares
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Halozyme Therapeutics
HALO
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Novo Nordisk
NVO
$100K-$200K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Moderna
MRNA
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Merck
MRK
$1K-$15K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Stock
Filed 2.8y ago· Aug 13, 2023
32 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
AbbVie
ABBV
$50K-$100K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Novartis Ag
NVS
$250K-$500K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Takeda Pharmaceutical
TAK
$15K-$50K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Limited American Depositary Shares
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Sanofi
SNY
$15K-$50K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
R
RHHBY
$50K-$100K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Depositary Shares
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Relay Therapeutics
RLAY
$50K-$100K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
AstraZeneca
AZN
$100K-$250K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Depositary Shares
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
GSK PLC
GSK
$15K-$50K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Zoetis
ZTS
$15K-$50K
+11.3% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Merck
MRK
$1K-$15K
−10.5% vs S&P 500
Trade dateApr 10, 2023
Stock
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Moderna
MRNA
$15K-$50K
−80.8% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Karuna Therapeutics, Inc
KRTX
$1K-$15K
Trade dateApr 10, 2023
Karuna Therapeutics
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
AbbVie
ABBV
$1K-$15K
+11.3% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Bristol-Myers Squibb
BMY
$50K-$100K
−33.5% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Amicus Therapeutics
FOLD
$1K-$15K
+43.5% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Mirati Therapeutics, Inc
MRTX
$1K-$15K
Trade dateApr 10, 2023
Mirati Therapeutics
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Pfizer
PFE
$15K-$50K
−47.7% vs S&P 500
Trade dateApr 10, 2023
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Sarepta Therapeutics
SRPT
$15K-$50K
+11.3% vs S&P 500
Trade dateApr 10, 2023
Filed 3.1y ago· Apr 17, 2023
17 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Incyte
INCY
$1K-$15K
+20.2% vs S&P 500
Trade dateMar 31, 2023
Filed 3.1y ago· Apr 17, 2023
17 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Mirati Therapeutics, Inc
MRTX
$1K-$15K
Trade dateMar 31, 2023
Mirati Therapeutics
Filed 3.1y ago· Apr 17, 2023
17 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
R
RHHBY
$1K-$15K
+29.3% vs S&P 500
Trade dateMar 31, 2023
Depositary Shares
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Pfizer
PFE
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Zoetis
ZTS
$1K-$15K
−71.2% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Pfizer
PFE
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Ionis Pharmaceuticals
IONS
$1K-$15K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Alnylam Pharmaceuticals
ALNY
$15K-$50K
+34.6% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Merck
MRK
$15K-$50K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Stock
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Bristol-Myers Squibb
BMY
$100K-$250K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Catalent, Inc
CTLT
$1K-$15K
Trade dateMar 6, 2023
Catalent
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Biomarin Pharmaceutical
BMRN
$1K-$15K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Jazz Pharmaceuticals PLC
JAZZ
$15K-$50K
+43.0% vs S&P 500
Trade dateMar 6, 2023
Shares
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
AbbVie
ABBV
$1K-$15K
+23.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Elanco Animal Health
ELAN
$1K-$15K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Eli Lilly
LLY
$1K-$15K
+215.9% vs S&P 500
Trade dateMar 6, 2023
Filed 3.2y ago· Mar 20, 2023
21 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+32.7% vs S&P 500
Trade dateFeb 27, 2023
Filed 3.2y ago· Mar 20, 2023
21 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Sanofi
SNY
$1K-$15K
+15.9% vs S&P 500
Trade dateFeb 27, 2023
Filed 3.2y ago· Mar 20, 2023
21 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
R
RHHBY
$15K-$50K
+15.9% vs S&P 500
Trade dateFeb 27, 2023
Depositary Shares
Filed 3.2y ago· Mar 20, 2023
45 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Eli Lilly
LLY
$1K-$15K
+11.9% vs S&P 500
Trade dateFeb 3, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Sarepta Therapeutics
SRPT
$1K-$15K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Jazz Pharmaceuticals PLC
JAZZ
$1K-$15K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Shares
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Merck
MRK
$1K-$15K
−5.6% vs S&P 500
Trade dateJan 31, 2023
Stock
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
AbbVie
ABBV
$1K-$15K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Fate Therapeutics
FATE
$1K-$15K
−72.3% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
24 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Eli Lilly
LLY
$1K-$15K
+11.4% vs S&P 500
Trade dateJan 31, 2023
Filed 3.3y ago· Feb 24, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
R
RHHBY
$15K-$50K
+21.3% vs S&P 500
Trade dateJan 13, 2023
Depositary Shares
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Jul 14, 2023 30 days to disclose | Flat·+0.0% +12.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Jazz Pharmaceuticals JAZZ Shares | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Halozyme Therapeutics HALO | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Novo Nordisk NVO | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $100K-$200K midpoint $150K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Moderna MRNA | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AbbVie ABBV | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Novartis Ag NVS | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $250K-$500K midpoint $375K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Takeda Pharmaceutical TAK Limited American Depositary Shares | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Sanofi SNY | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | R RHHBY Depositary Shares | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Relay Therapeutics RLAY | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AstraZeneca AZN Depositary Shares | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $100K-$250K midpoint $175K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | GSK PLC GSK | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Johnson & Johnson JNJ | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Zoetis ZTS | Apr 10, 2023 39 days to disclose | Flat·+0.0% +11.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Merck MRK Stock | Apr 10, 2023 39 days to disclose | Good buy·+$67+0.8% −10.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Moderna MRNA | Apr 10, 2023 39 days to disclose | Bad buy·−$22.6K-69.5% −80.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Karuna Therapeutics KRTX Karuna Therapeutics | Apr 10, 2023 39 days to disclose | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AbbVie ABBV | Apr 10, 2023 39 days to disclose | Flat·+0.0% +11.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Bristol-Myers Squibb BMY | Apr 10, 2023 39 days to disclose | Bad buy·−$16.6K-22.2% −33.5% vs S&P 500 | $50K-$100K midpoint $75K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Amicus Therapeutics FOLD | Apr 10, 2023 39 days to disclose | Missed gain·−$2.5K-30.8% +43.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Mirati Therapeutics MRTX Mirati Therapeutics | Apr 10, 2023 39 days to disclose | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Pfizer PFE | Apr 10, 2023 39 days to disclose | Bad buy·−$11.8K-36.4% −47.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Sarepta Therapeutics SRPT | Apr 10, 2023 39 days to disclose | Flat·+0.0% +11.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Incyte INCY | Mar 31, 2023 17 days to disclose | Good buy·+$2.8K+34.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Mirati Therapeutics MRTX Mirati Therapeutics | Mar 31, 2023 17 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | R RHHBY Depositary Shares | Mar 31, 2023 17 days to disclose | Good buy·+$3.5K+44.0% +29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Pfizer PFE | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Zoetis ZTS | Mar 7, 2023 41 days to disclose | Bad buy·−$4.3K-54.3% −71.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Pfizer PFE | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Ionis Pharmaceuticals IONS | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Alnylam Pharmaceuticals ALNY | Mar 6, 2023 42 days to disclose | Good buy·+$16.1K+49.6% +34.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Merck MRK Stock | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $100K-$250K midpoint $175K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Catalent, Inc CTLT Catalent | Mar 6, 2023 42 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Biomarin Pharmaceutical BMRN | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Jazz Pharmaceuticals JAZZ Shares | Mar 6, 2023 42 days to disclose | Good buy·+$18.9K+58.1% +43.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | AbbVie ABBV | Mar 6, 2023 42 days to disclose | Good buy·+$3K+38.0% +23.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Elanco Animal Health ELAN | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Eli Lilly LLY | Mar 6, 2023 42 days to disclose | Good buy·+$18.5K+230.9% +215.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Johnson & Johnson JNJ | Feb 27, 2023 21 days to disclose | Good buy·+$3.9K+48.6% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Sanofi SNY | Feb 27, 2023 21 days to disclose | Flat·+0.0% +15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | R RHHBY Depositary Shares | Feb 27, 2023 21 days to disclose | Flat·+0.0% +15.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Eli Lilly LLY | Feb 3, 2023 45 days to disclose | Flat·+0.0% +11.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Sarepta Therapeutics SRPT | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Jazz Pharmaceuticals JAZZ Shares | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Merck MRK Stock | Jan 31, 2023 24 days to disclose | Good buy·+$458+5.7% −5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | AbbVie ABBV | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Fate Therapeutics FATE | Jan 31, 2023 24 days to disclose | Bad buy·−$4.9K-60.9% −72.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Eli Lilly LLY | Jan 31, 2023 24 days to disclose | Flat·+0.0% +11.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 24, 2023 3.3y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | R RHHBY Depositary Shares | Jan 13, 2023 42 days to disclose | Good buy·+$10.1K+30.9% +21.3% vs S&P 500 | $15K-$50K midpoint $32.5K |